カート
レポートナンバー 0000039130
VPGMarketResearch
2024 Japan Infectious Disease Molecular Diagnostics Market for 100 Tests: Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review
発刊日 2024/07/01
言語英語
体裁PDF
ライセンス/価格
0000039130
※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。 ※本レポートは、英文です。電子媒体での納品となります。 ※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。
無料サンプル
本レポートはセクション別、市場セグメント別、個々の検査別に提供されており、特定の情報ニーズや予算に合わせてカスタマイズできます。
この新しい調査は、現在のサプライヤーと潜在的な市場参入者が、今後 5 年間の感染症分子診断市場における新たな機会を特定し、評価するのに役立つように設されています。
レポートのハイライト
論理的根拠
感染症分子診断市場は、体外診断業界で最も急速に成長している分野の1つです。今後5年間で、試薬システムと自動化の大きな進歩、そして革新的なマーケティングアプローチを必要とする幅広い新製品の導入が見られるでしょう。しかし、日常的な臨床検査室への市場浸透率は、増幅法を備えた費用対効果の高い自動化システムの導入にかかっています。
感染症分子診断市場がもたらす機会をうまく活用するために、多くの企業がすでに新しい分子技術を企業戦略資産として活用し、ビジネスおよびマーケティング戦略をサポートする形で管理しています。新しい技術計画をビジネスおよび企業戦略と統合することは、今後 5 年間で診断企業にとって最も困難な課題の 1 つとなるでしょう。
日本市場の概要
市場セグメンテーション分析
製品/技術レビュー
競争力評価
機会と戦略的推奨事項
Table of Contents I. Introduction II. Major Product Development Opportunities A. Instrumentation B. Reagent Kits and Test Systems/panels C. Computers, Software and Automation D. Auxiliary Products III. Design Criteria for Decentralized Testing Products IV. Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts D. Distribution Strategies For Decentralized Testing Markets V. Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge And Limitations E. Patent Protection F. Regulatory Constraints G. Decentralized Testing Market Challenges VI. Worldwide Market and Technology Review A. DNA Sequencing 1. Introduction 2. Sequencing Methods 3. Autoradiography 4. The Human Genome Project 5. Sequencing Automation 6. Image Scanners 7. Fluorescent Detection 8. Gene Profiling 9. Gene Expression 10. Polymorphism Screening 11. Protein Interaction Networks B. DNA and RNA Probe Technologies 1. Basic Principles 2. Probe Preparation 3. The DNA Probe Test 4. Test Formats 5. Labeling Techniques 6. Amplification Methods C. Detection Technologies 1. Radioactive Methods a. Overview b. Major Isotopes O P-32 O S-35 O H-3 O I-125 2. Non-Isotopic Methods a. Enzymatic Labels b. Chemical Labeling O Indirect Chemical Labeling O Direct Chemical Labeling c. Fluorescence d. Chemiluminescence e. Electrical Conductivity D. Molecular Diagnostic Instrumentation Review 1. Abbott LCx 2. Beckman Coulter/Biomek FK 3. BD Viper System with XTR Technology 4. BD Innova 5. Becton Dickinson SDA 6. bioMerieux NucliSENS easyMAG 7. bioMerieux NucliSENS easyQ and MiniMAG 8. Bio-Rad GeneScope 9. Cepheid GeneXpert 10. Curetis Unyvero 11. GenMark Dx eSensor XT-8 12. Hologic/Gen-Probe Panther 13. Hologic/Gen-Probe Tigris/DTS 14. HTG Molecular Edge 15. Life Technologies QuantStudio Dx 16. Qiagen QIAsymphony RGQ 17. Roche Cobas Amplicor 18. Roche Cobas TaqMan 48 19. Roche Cobas TaqMan 20. Roche Cobas TaqMan AmpliPrep 21. Roche LighCycler 480 22. Roche Cobas 4800 23. Roche Cobas s 201 24. Siemens Versant 25. Tecan LS Series E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip - Liquid Transportation and Mixing - Separation - Reaction - Detection F. Pharmacogenomics G. Major Applications, Microbiology/Infectious Diseases a. Overview b. Major Infectious Diseases ° AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II ° Adenovirus ° Aeromonas ° Anthrax/Bacillus Anthracis ° Arboviruses ° Babesiosis ° Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea) ° Blastocystis Hominis ° Brucella ° Campylobacter ° Candida ° Chagas Disease ° Chancroid ° Chlamydia ° Clostridium Difficile ° Coronaviruses ° Coxsackieviruses ° Creutzfeldt-Jakob’s Disease ° Cryptosporidium Parvum ° Cyclospora Cayetanensis ° Cytomegalovirus ° Ebola Virus ° E. Coli ° EchoVirus ° Encephalitis ° Enteroviruses ° Epstein-Barr Virus ° Giardia Lamblia ° Gonorrhea ° Granuloma Inguinale ° Hantavirus ° Helicobacter Pylori ° Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, ALT/SGPT ° Herpes Simplex Virus ° Human Herpes Virus-6 (HHV-6) ° Influenza Viruses ° Legionella ° Lyme Disease ° Lymphogranuloma Venereum (LGV) ° Malaria ° Measles (Rubeola) ° Meningitis ° Microsporidium ° Mononucleosis ° Mumps ° Mycoplasma ° Papillomaviruses ° Parvovirus B19 ° Pneumonia ° Polyomaviruses ° Pseudomonas Aeruginosa ° Rabies ° Respiratory Syncytial Virus (RSV) ° Rhinoviruses ° Rotavirus ° Rubella ° Salmonellosis ° Septicemia ° Shigellosis ° Staphylococcus Aureus ° Streptococci ° Syphilis ° Toxoplasmosis ° Trichomonas Vaginalis ° Tuberculosis ° Vibrio ° West Nile Virus ° Yersina H. Competing/complementing 1. Monoclonal Antibodies/Immunoassays 2. RNA Probes 3. Two-Dimensional Electrophoresis 4. Flow Cytometry VII. Japan Molecular Diagnostics Market A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares VIII. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - Decode Genetics - Diadexus - Eiken Chemical - Elitech Group - Enzo Biochem - Exact Sciences - Fujirebio - Grifols - Hologic - Illumina - LabCorp - Leica Biosystems - Li-Cor Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - PerkinElmer - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens Healthineers - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher XIII. Appendix: Major Universities and Research Centers Developing Molecular Diagnostic Technologies
List of Tables Major Companies Developing or Marketing AIDS Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Adenovirus Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Bartonella Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Campylobacter Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Candida Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Chlamydia Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Clostridium Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Coronavirus Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Cryptosporidium Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing CMV Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Echovirus Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Enterovirus Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing EBV Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Giardia Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Hantavirus Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Helicobacter Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Hepatitis Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Herpes Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Influenza Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Legionella Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Measles Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Meningitis Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Mononucleosis Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Mumps Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Pneumonia Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing RSV Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Rotavirus Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Rubella Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Salmonella Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Septicemia Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Shigella Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Streptococci Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Syphilis Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Trichomonas Molecular Diagnostic and Other Direct Identification Tests Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic and Other Direct Identification Tests Japan Molecular Diagnostics Test Volume And Sales By Major Application Japan Laboratories Performing DNA Sequencing By Market Segment Japan Molecular Diagnostics Market Potential Laboratory Universe by Market Segment Japan Molecular Diagnostics Test Volume by Major Application Japan Major Infectious Disease Test Volume by Assay Japan Major Infectious Disease Test Volume by Method Japan Molecular Diagnostics Market by Major Application Japan Molecular Diagnostics Market Estimated Sales And Market Shares of Major Suppliers Japan Major Infectious Disease Diagnostics Market by Assay Japan AIDS Testing Market Estimated Sales by Major Supplier Japan Chlamydia Testing Market Estimated Sales by Major Supplier Japan CMV Testing Market Estimated Sales by Major Supplier Japan Gonorrhea Testing Market Estimated Sales by Major Supplier Japan Hepatitis Testing Market Estimated Sales by Major Supplier Japan Hepatitis C Testing Market Estimated Sales by Major Supplier Japan Herpes Testing Market Estimated Sales by Major Supplier Japan Meningitis Testing Market Estimated Sales by Major Supplier Japan Mycoplasma Testing Market Estimated Sales by Major Supplier Japan Pneumonia Testing Market Estimated Sales by Major Supplier Japan Shigella Testing Market Estimated Sales by Major Supplier
この商品のレポートナンバー
Global Nebulizer Market Size Study, by Type (Jet, Mesh, Ultrasonic), by Application (COPD, Asthma, Cystic Fibrosis), by End-use (Hospitals & Clinics, Emergency Centers, Home Healthcare), and Regional Forecasts 2022-2032
2025/03/10
4,950 USD
